Search clinical trials for: low-dose ticagrelor

Total 616 results

AstraZeneca

Completed

A Study of the Onset and Offset of Antiplatelet Effects Comparing Ticagrelor, Clopidogrel, and Placebo With Aspirin

Coronary Artery Disease

United States, United Kingdom
Federal University of São Paulo

Unknown

Efficacy and Safety of Low-dose Oral Isotretinoin for Seborrhea

Quality of Life | Seborrheic Dermatitis | Seborrhea

Brazil
AstraZeneca

Completed

A Study of the Antiplatelet Effects Comparing Ticagrelor (Ticag. - AZD6140) With Clopidogrel (Clop.) Responder and Non-responders (RESPOND)

Stable Coronary Artery Disease

United States, Canada, Denmark, United Kingdom
Seoul National University Bundang Hospital
GE Healthcare; National Research Foundation of Korea

Completed

Diagnosis of Acute Appendicitis: Low-dose Computed Tomography (CT) Versus Standard-dose CT

Appendicitis

Korea, Republic of
University of Cologne

Completed

Feasibility and Efficacy of BACOPP-21 for Patients > 60 Years With Intermediate or Advanced Hodgkins Lymphoma

Hodgkin´s Lymphoma

Germany
Herlev Hospital
Odense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark

Completed

Neoadjuvant Pegylated Liposomal Doxorubicin and Cyclophosphamide +/- Trastuzumab Followed by Docetaxel in Breast Cancer

Breast Cancer

Denmark
University Hospital, Ghent
Fund for Scientific Research, Flanders, Belgium

Completed

Psychosocial and Physiological Mechanisms in the Effect of Hormonal Contraception on the Female Sexual Desire

Healthy

Belgium
AstraZeneca

Completed

Study to Investigate the Effects of AZD6140 in Patients With Renal Impairment and in Healthy Volunteers

Renal Impairment

United States
AstraZeneca

Completed

An Open-Label, Single and Multiple Dose Pharmacokinetic Study of 90 mg and 180 mg Doses of AZD6140 in Healthy Volunteers

Pharmacokinetics

China
AstraZeneca

Completed

Uric Acid Study in Healthy Male Volunteers

Coronary Artery Disease | Gout
AstraZeneca

Completed

AZD6140 Oral Contraceptive Interaction Study

Healthy

United States
University of Virginia

Completed

Trial for the Evaluation of the Effect of Systemic Low-dose Interleukin-2 (IL-2) on the Immunogenicity of a Vaccine Comprising Synthetic Melanoma Peptides Administered With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With High Risk Melanoma (MEL36)

Melanoma
Larissa University Hospital

Unknown

Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial (DAD-HF)

Acute Heart Failure

Greece
Teva Pharmaceuticals USA

Completed

Moexipril HCl/Hydrochlorothiazide 15/25 mg Tablets Under Non-Fasting Conditions

Healthy

United States
Amgen

Completed

Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy

Anemia | Non-Small Cell Lung Cancer
Johann Wolfgang Goethe University Hospital

Completed

Fish Oil and Asthma in House Dust Mite Allergy

Allergic Asthma | House Dust Mite Allergy | Bronchial Inflammation

3

Subscribe